Frank Rimerman Advisors LLC Has $1.99 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Frank Rimerman Advisors LLC cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,632 shares of the company’s stock after selling 133 shares during the period. Frank Rimerman Advisors LLC’s holdings in HCA Healthcare were worth $1,991,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Legacy Investment Solutions LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter worth approximately $39,000. Whipplewood Advisors LLC acquired a new position in shares of HCA Healthcare during the 4th quarter valued at $31,000. Activest Wealth Management lifted its position in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after acquiring an additional 125 shares during the period. Pinnacle Bancorp Inc. lifted its position in shares of HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after acquiring an additional 50 shares during the period. Finally, Eastern Bank bought a new stake in HCA Healthcare during the 4th quarter valued at $62,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.60% of the stock is owned by insiders.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $319.82 on Friday. The stock has a fifty day moving average of $319.00 and a 200 day moving average of $345.57. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The firm has a market capitalization of $78.74 billion, a price-to-earnings ratio of 14.56, a PEG ratio of 1.10 and a beta of 1.68. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the business earned $5.90 earnings per share. As a group, research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.90%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on HCA. KeyCorp reduced their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Barclays reduced their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research report on Monday, January 27th. Truist Financial dropped their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Royal Bank of Canada dropped their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a report on Monday, January 27th. Finally, JPMorgan Chase & Co. reissued a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a report on Tuesday, December 17th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.